Literature DB >> 6300227

Bordetella pertussis isolation in general practice: 1977-79 whooping cough epidemic in West Glamorgan.

W Kwantes, D H Joynson, W O Williams.   

Abstract

Some of the factors influencing the isolation rate of Bordetella pertussis during a whooping cough epidemic in West Glamorgan, Wales, are reported. The organism was isolated from 39% of patients with clinical whooping cough, pernasal swabbing being much more successful than cough plates. Isolation rates were increased in the non-immunized, particularly in the first year of life. Erythromycin and co-trimoxazole significantly reduced the isolation rate of B. pertussis but this did not occur with penicillin. In this study 20% of patients were culture positive 6 weeks after the onset of their infection. It is suggested that the Department of Health and Social Security recommendation of a minimum period of three weeks exclusion of children from school is inadequate. During the epidemic, the proportion of strains of B. pertussis containing antigen 2 more than doubled.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300227      PMCID: PMC2134260          DOI: 10.1017/s0022172400028825

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  3 in total

1.  Prevalent serotypes of Bordetella pertussis in non-vaccinated communities.

Authors:  N W Preston
Journal:  J Hyg (Lond)       Date:  1976-08

2.  Selective medium for the isolation of bordetella pertussis and parapertussis.

Authors:  E M Sutcliffe; J D Abbott
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

3.  The whooping cough syndrome: A continuing pediatric problem.

Authors:  J Islur; C S Anglin; P J Middleton
Journal:  Clin Pediatr (Phila)       Date:  1975-02       Impact factor: 1.168

  3 in total
  16 in total

1.  Pertussis: the disease and the vaccine.

Authors:  R Gold
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

2.  Evaluation of serologic assays for diagnosis of whooping cough.

Authors:  G Granström; B Wretlind; C R Salenstedt; M Granström
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 3.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 4.  Treatment and prevention of pertussis by antimicrobial agents (Part II).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 5.  Methods for isolation of Bordetella pertussis from patients with whooping cough.

Authors:  J E Hoppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

6.  Isolation of Bordetella pertussis: benefits of using both Bordet-Gengou and charcoal agar media.

Authors:  F Ahmad; M A Calder
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

7.  Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; F Arminjon; I Krantz; T Lagergård; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

8.  Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; I Krantz; T Lagergård; P Larsson; R Sekura; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

9.  Survival of Bordetella pertussis in transport media.

Authors:  P R Hunter
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

10.  Issues associated with and recommendations for using PCR to detect outbreaks of pertussis.

Authors:  Fabio A Lievano; Meredith A Reynolds; Alfred L Waring; Joel Ackelsberg; Kristine M Bisgard; Gary N Sanden; Dalya Guris; Anne Golaz; Dianna J Bopp; Ronald J Limberger; Perry F Smith
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.